SHARE

EIT Health-supported SpotLab celebrates market launch

17th March 2023

Spanish start-up, SpotLab, has launched an intelligent fully integrated mobile platform for remote analysis of medical images to the market. They are also celebrating their first sales to pharmaceutical companies and global health institutions. 

Founded by María Postigo Camps, who attended EIT Health’s Women Entrepreneurship Bootcamp in 2021, Spotlab is a social enterprise that creates artificial intelligence with clinical impact. The healthtech start-up is a spin-off from Universidad Politécnica de Madrid. 

SpotLab’s innovative solution for biomedical research and diagnostics transforms smartphones into medical devices. It uses 3D printing to acquire images that are analysed through artificial intelligence (AI). Their aim is to achieve universal healthcare for all by bringing AI to diseases that are not yet in the digital world. 

SpotLab’s Founder, María, found EIT Health’s Women Entrepreneurship Bootcamp incredibly helpful to develop the company’s business plan and present it to investors. María’s mentor helped her present the start-up’s innovations, value proposition, and market fit in a clear and compelling manner.  

“It’s been an exceptional Bootcamp. With key lessons to deepen our understanding of the health sector, and to empower our tools as entrepreneurs. An occasion to expand personal and professional networks at the international level. With brilliant entrepreneurs, and relevant mentors and stakeholders within the health-tech sector,” said María. 

Applications for our next Women Entrepreneurship Bootcamp close 20 March 2023. Learn more and apply now.  

How can young scientists move to innovation roles?

How can young scientists move to innovation roles?

Q&A with Carmen Schweicker

Find out more

EIT Health named top business accelerator by UBI Global

EIT Health named top business accelerator by UBI Global

Learn more about the achievement

Find out more

Arthex Biotech closes a €42M Series B financing round

Arthex Biotech closes a €42M Series B financing round

Find out more about our support

Find out more